US2019125695A1PendingUtilityA1

Carotenoid-containing cognitive function improving composition for use in exercise therapy for improving cognitive function

32
Assignee: ASTAREAL CO LTDPriority: Jun 8, 2016Filed: Jun 7, 2017Published: May 2, 2019
Est. expiryJun 8, 2036(~9.9 yrs left)· nominal 20-yr term from priority
Inventors:Hideaki SoyaJangsoo Yook
A61K 31/015A61K 36/05A23V 2002/00A61K 31/122A23L 33/10A61P 25/00
32
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a carotenoid-containing composition for use in exercise therapy for improving cognitive function, particularly exercise therapy for hippocampal neurogenesis.

Claims

exact text as granted — not AI-modified
1 . A cognitive function improving composition comprising carotenoid for use in exercise therapy for improving cognitive function. 
     
     
         2 . A memory function improving composition comprising carotenoid for use in exercise therapy for improving memory function. 
     
     
         3 . A learning function improving composition comprising carotenoid for use in exercise therapy for improving learning function. 
     
     
         4 . A hippocampal neurogenesis composition comprising carotenoid for use in exercise therapy for hippocampal neurogenesis. 
     
     
         5 . The composition according to  claim 1 , wherein the carotenoid is astaxanthin. 
     
     
         6 . The composition according to  claim 5 , wherein the astaxanthin is derived from  Haematococcus  algae. 
     
     
         7 . The composition according to  claim 1 , wherein it is for continuous ingestion for at least 4 weeks. 
     
     
         8 . The composition according to  claim 1 , wherein the exercise therapy is low intensity exercise therapy. 
     
     
         9 . The composition according to  claim 8 , wherein the low intensity exercise is an exercise of a ventilatory work threshold value or less. 
     
     
         10 . The composition according to  claim 1 , wherein it is by upregulation of at least one gene selected from the group consisting of Igf1r, Lep and Cxcr4 genes. 
     
     
         11 . The composition according to  claim 1 , wherein it is a medicine or a food.

Join the waitlist — get patent alerts

Track US2019125695A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.